On February 7, 2024 Humanetics Corporation (Humanetics), a clinical-stage specialty pharmaceutical company pioneering radiation countermeasures, adjunctive oncology therapies, and pulmonary protective therapies, reported that it will present and participate in several investor and partnering conferences in February (Press release, Humanetics, FEB 7, 2024, View Source [SID1234639925]). Ronald J. Zenk, Chief Executive Officer at Humanetics, along with members of management and the board of directors, will present an overview of the company and hold one-on-one meetings with potential investors and partners at the following conferences:
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
Emerging Growth Conference, February 7-8, 2024 (virtual)
The Emerging Growth Conference features companies in a wide range of growth sectors with strong management teams, innovative products and services, and focused strategy and execution. The potential audience includes tens of thousands of individual and institutional investors, investment advisors, and analysts. For more information about the Emerging Growth Conference, visit Emerging Growth Conference – EmergingGrowth.com.
Presentation Date: Wednesday, February 7, 2024
Presentation Time: 1:45-2:15 PM Eastern Time
Webcast link: View Source;tp_key=d1cd45a6dc&sti=humanetics
Oppenheimer 34th Annual Healthcare Life Sciences Conference, February 13-14, 2024 (virtual)
This conference provides investors with a broad spectrum of public and private healthcare companies spanning all major sectors of the healthcare industry: bio and specialty pharmaceuticals; biotechnology; medical devices; life science tools and diagnostics; healthcare information technology and distribution; and healthcare providers and servicers.
Presentation date: Tuesday, February 13, 2024
Presentation time: 3:20-3:50 PM Eastern Time
Webcast link: View Source
BIO CEO & Investor Conference, February 26-27, 2024, New York, NY
Sponsored by the Biotechnology Industry Organization (BIO), the BIO CEO & Investor Conference is one of the largest investor conferences focused on established and emerging publicly traded, late-stage private biotech companies. Event registration: Register for the BIO CEO & Investor Conference.
Presentation date: Tuesday, February 26, 2024
Presentation time: 10:15 AM Eastern Time
Presentation location: New York Marriott Marquis, Royale Room
17th Annual European Life Sciences CEO Forum, February 28-29th, 2024, Zurich, Switzerland; March 6-8, 2024 (virtual)
The conference is expected to include 400+ delegates from all life sciences sectors, with a target audience that includes corporate and financial investors/partners, banks, and advisors. There will be a global company showcase of 50+ presentations by established public, private, emerging, and seed companies offering innovative solutions and seeking investment and partnering opportunities. This will include a limited number of live presentations on dedicated presentation tracks, alongside virtual company showcases available on demand during the virtual week. For more information, visit About the 17th Annual European Life Sciences CEO Forum (sachsforum.com).
Presentation location: Zurich Hilton Zurich Airport Hotel